FarFaR - Pharmacy Repository
University of Belgrade, Faculty of Pharmacy
    • English
    • Српски
    • Српски (Serbia)
  • English 
    • English
    • Serbian (Cyrillic)
    • Serbian (Latin)
  • Login
View Item 
  •   FarFaR
  • Pharmacy
  • Radovi istraživača / Researchers’ publications
  • View Item
  •   FarFaR
  • Pharmacy
  • Radovi istraživača / Researchers’ publications
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Monitoring of complex forming of the active pharmaceutical substance and β-cyclodextrin as an additive of the mobile phase using mass spectrometry

Praćenje građenja kompleksa aktivne farmaceutske supstance i β-ciklodekstrina kao aditiva mobilne faze primenom masene spektrometrije

Thumbnail
2016
2727.pdf (595.7Kb)
Authors
Milenković, Anđela
Miljić, Dragana
Mitrović, Jelena
Protić, Ana
Otašević, Biljana
Article (Published version)
Metadata
Show full item record
Abstract
In recent years, there is aim to reduce toxic solvents use in chromatographic techniques. Beta-cyclodextrins (β-CD) are commonly used for this purpose, as substance retention modulators. By increasing their concentration in the mobile phase, generally there is a decrease in analyte retention time, and consequently, a decrease in the organic solvent ratio in the mobile phase. The aim of this study was to investigate β-CD and selected sartans inclusion complexes formation. The emphasis was on the influence of the aqueous phase pH value, the drug-β-CD molar ratio and the organic solvent type on complex formation. The mass spectrometry investigation included characterization of the formed complex drug: β-CD at different molar ratios (1:1, 1:2, 1:5 and 1:10), and at different pH values of the aqueous phase (5, 7 and 9) using triple quadrupole mass analyzer. The mobile phase and solvent in which the complexes were formed consisted of acetonitrile and water mixture (50:50, v/v) and methanol a...nd water mixture (50:50, v/v). Measurements of these complexes signal intensity after electrospray ionization in negative mode. Observed m/z values indicated formation of drug-β-CD in 1:1 ratio at all pH values of water phase and independently of organic solvent type and β-CD ratio. It was noted that formed complex signal intensity increased only by increasing β-CD ratio.

Poslednjih godina sve više se teži smanjenju upotrebe toksičnih rastvarača u hromatografskim metodama. U te svrhe često se upotrebljavaju beta-ciklodekstrini (β-CD) kao modulatori retencije supstanci. Povećavanjem njihove koncentracije u mobilnoj fazi uglavnom dolazi do smanjenja retencije analita i, posledično, do smanjenja udela organskog rastvarača u mobilnoj fazi. Cilj rada bio je ispitivanje načina formiranja inkluzionih kompleksa β-CD i odabranih lekova iz grupe sartana, sa posebnim osvrtom na uticaj pH vrednosti vodene faze, molarnog odnosa leka i β-CD i vrste organskog rastvarača na formiranje kompleksa. Primenom metode masene spektrometrije, na triplkvadrupolskom masenom analizatoru, vršena je karakterizacija formiranog kompleksa β-CD i leka pri različitom molarnom odnosu lek:β-CD (1:1, 1:2, 1:5 i 1:10) i pri pH vrednostima vodene faze 5, 7 i 9. Mobilna faza i rastvarač u kome su formirani kompleksi bila je smeša acetonitrila i vode, kao i smeša metanola i vode (50:50, V/V). M...erenja intenziteta signala nagrađenih kompleksa nakon elektrosprej jonizacije vršena su u negativnom modu. Uočene su m/z vrednosti koje potiču od masa kompleksa leka i β-CD u odnosu 1:1 pri svim pH vrednostima vodene faze i nezavisno od vrste organskog rastvarača i udela β-CD. Uočeno je da intenzitet signala nastalog kompleksa raste jedino povećanjem udela β-CD.

Keywords:
mass spectrometry / inclusion complex / beta-cyclodextrins / sartans / masena spektrometrija / inkluzioni kompleksi / beta-ciklodekstrin / sartani
Source:
Arhiv za farmaciju, 2016, 66, 4, 147-160
Publisher:
  • Savez farmaceutskih udruženja Srbije, Beograd
Funding / projects:
  • Synthesis, Quantitative Structure and Activity Relationship, Physico-Chemical Characterisation and Analysis of Pharmacologically Active Substances (RS-172033)

DOI: 10.5937/arhfarm1604147M

ISSN: 0004-1963

Scopus: 2-s2.0-85019150994
[ Google Scholar ]
URI
https://farfar.pharmacy.bg.ac.rs/handle/123456789/2729
Collections
  • Radovi istraživača / Researchers’ publications
Institution/Community
Pharmacy
TY  - JOUR
AU  - Milenković, Anđela
AU  - Miljić, Dragana
AU  - Mitrović, Jelena
AU  - Protić, Ana
AU  - Otašević, Biljana
PY  - 2016
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/2729
AB  - In recent years, there is aim to reduce toxic solvents use in chromatographic techniques. Beta-cyclodextrins (β-CD) are commonly used for this purpose, as substance retention modulators. By increasing their concentration in the mobile phase, generally there is a decrease in analyte retention time, and consequently, a decrease in the organic solvent ratio in the mobile phase. The aim of this study was to investigate β-CD and selected sartans inclusion complexes formation. The emphasis was on the influence of the aqueous phase pH value, the drug-β-CD molar ratio and the organic solvent type on complex formation. The mass spectrometry investigation included characterization of the formed complex drug: β-CD at different molar ratios (1:1, 1:2, 1:5 and 1:10), and at different pH values of the aqueous phase (5, 7 and 9) using triple quadrupole mass analyzer. The mobile phase and solvent in which the complexes were formed consisted of acetonitrile and water mixture (50:50, v/v) and methanol and water mixture (50:50, v/v). Measurements of these complexes signal intensity after electrospray ionization in negative mode. Observed m/z values indicated formation of drug-β-CD in 1:1 ratio at all pH values of water phase and independently of organic solvent type and β-CD ratio. It was noted that formed complex signal intensity increased only by increasing β-CD ratio.
AB  - Poslednjih godina sve više se teži smanjenju upotrebe toksičnih rastvarača u hromatografskim metodama. U te svrhe često se upotrebljavaju beta-ciklodekstrini (β-CD) kao modulatori retencije supstanci. Povećavanjem njihove koncentracije u mobilnoj fazi uglavnom dolazi do smanjenja retencije analita i, posledično, do smanjenja udela organskog rastvarača u mobilnoj fazi. Cilj rada bio je ispitivanje načina formiranja inkluzionih kompleksa β-CD i odabranih lekova iz grupe sartana, sa posebnim osvrtom na uticaj pH vrednosti vodene faze, molarnog odnosa leka i β-CD i vrste organskog rastvarača na formiranje kompleksa. Primenom metode masene spektrometrije, na triplkvadrupolskom masenom analizatoru, vršena je karakterizacija formiranog kompleksa β-CD i leka pri različitom molarnom odnosu lek:β-CD (1:1, 1:2, 1:5 i 1:10) i pri pH vrednostima vodene faze 5, 7 i 9. Mobilna faza i rastvarač u kome su formirani kompleksi bila je smeša acetonitrila i vode, kao i smeša metanola i vode (50:50, V/V). Merenja intenziteta signala nagrađenih kompleksa nakon elektrosprej jonizacije vršena su u negativnom modu. Uočene su m/z vrednosti koje potiču od masa kompleksa leka i β-CD u odnosu 1:1 pri svim pH vrednostima vodene faze i nezavisno od vrste organskog rastvarača i udela β-CD. Uočeno je da intenzitet signala nastalog kompleksa raste jedino povećanjem udela β-CD.
PB  - Savez farmaceutskih udruženja Srbije, Beograd
T2  - Arhiv za farmaciju
T1  - Monitoring of complex forming of the active pharmaceutical substance and β-cyclodextrin as an additive of the mobile phase using mass spectrometry
T1  - Praćenje građenja kompleksa aktivne farmaceutske supstance i β-ciklodekstrina kao aditiva mobilne faze primenom masene spektrometrije
VL  - 66
IS  - 4
SP  - 147
EP  - 160
DO  - 10.5937/arhfarm1604147M
ER  - 
@article{
author = "Milenković, Anđela and Miljić, Dragana and Mitrović, Jelena and Protić, Ana and Otašević, Biljana",
year = "2016",
abstract = "In recent years, there is aim to reduce toxic solvents use in chromatographic techniques. Beta-cyclodextrins (β-CD) are commonly used for this purpose, as substance retention modulators. By increasing their concentration in the mobile phase, generally there is a decrease in analyte retention time, and consequently, a decrease in the organic solvent ratio in the mobile phase. The aim of this study was to investigate β-CD and selected sartans inclusion complexes formation. The emphasis was on the influence of the aqueous phase pH value, the drug-β-CD molar ratio and the organic solvent type on complex formation. The mass spectrometry investigation included characterization of the formed complex drug: β-CD at different molar ratios (1:1, 1:2, 1:5 and 1:10), and at different pH values of the aqueous phase (5, 7 and 9) using triple quadrupole mass analyzer. The mobile phase and solvent in which the complexes were formed consisted of acetonitrile and water mixture (50:50, v/v) and methanol and water mixture (50:50, v/v). Measurements of these complexes signal intensity after electrospray ionization in negative mode. Observed m/z values indicated formation of drug-β-CD in 1:1 ratio at all pH values of water phase and independently of organic solvent type and β-CD ratio. It was noted that formed complex signal intensity increased only by increasing β-CD ratio., Poslednjih godina sve više se teži smanjenju upotrebe toksičnih rastvarača u hromatografskim metodama. U te svrhe često se upotrebljavaju beta-ciklodekstrini (β-CD) kao modulatori retencije supstanci. Povećavanjem njihove koncentracije u mobilnoj fazi uglavnom dolazi do smanjenja retencije analita i, posledično, do smanjenja udela organskog rastvarača u mobilnoj fazi. Cilj rada bio je ispitivanje načina formiranja inkluzionih kompleksa β-CD i odabranih lekova iz grupe sartana, sa posebnim osvrtom na uticaj pH vrednosti vodene faze, molarnog odnosa leka i β-CD i vrste organskog rastvarača na formiranje kompleksa. Primenom metode masene spektrometrije, na triplkvadrupolskom masenom analizatoru, vršena je karakterizacija formiranog kompleksa β-CD i leka pri različitom molarnom odnosu lek:β-CD (1:1, 1:2, 1:5 i 1:10) i pri pH vrednostima vodene faze 5, 7 i 9. Mobilna faza i rastvarač u kome su formirani kompleksi bila je smeša acetonitrila i vode, kao i smeša metanola i vode (50:50, V/V). Merenja intenziteta signala nagrađenih kompleksa nakon elektrosprej jonizacije vršena su u negativnom modu. Uočene su m/z vrednosti koje potiču od masa kompleksa leka i β-CD u odnosu 1:1 pri svim pH vrednostima vodene faze i nezavisno od vrste organskog rastvarača i udela β-CD. Uočeno je da intenzitet signala nastalog kompleksa raste jedino povećanjem udela β-CD.",
publisher = "Savez farmaceutskih udruženja Srbije, Beograd",
journal = "Arhiv za farmaciju",
title = "Monitoring of complex forming of the active pharmaceutical substance and β-cyclodextrin as an additive of the mobile phase using mass spectrometry, Praćenje građenja kompleksa aktivne farmaceutske supstance i β-ciklodekstrina kao aditiva mobilne faze primenom masene spektrometrije",
volume = "66",
number = "4",
pages = "147-160",
doi = "10.5937/arhfarm1604147M"
}
Milenković, A., Miljić, D., Mitrović, J., Protić, A.,& Otašević, B.. (2016). Monitoring of complex forming of the active pharmaceutical substance and β-cyclodextrin as an additive of the mobile phase using mass spectrometry. in Arhiv za farmaciju
Savez farmaceutskih udruženja Srbije, Beograd., 66(4), 147-160.
https://doi.org/10.5937/arhfarm1604147M
Milenković A, Miljić D, Mitrović J, Protić A, Otašević B. Monitoring of complex forming of the active pharmaceutical substance and β-cyclodextrin as an additive of the mobile phase using mass spectrometry. in Arhiv za farmaciju. 2016;66(4):147-160.
doi:10.5937/arhfarm1604147M .
Milenković, Anđela, Miljić, Dragana, Mitrović, Jelena, Protić, Ana, Otašević, Biljana, "Monitoring of complex forming of the active pharmaceutical substance and β-cyclodextrin as an additive of the mobile phase using mass spectrometry" in Arhiv za farmaciju, 66, no. 4 (2016):147-160,
https://doi.org/10.5937/arhfarm1604147M . .

DSpace software copyright © 2002-2015  DuraSpace
About FarFaR - Pharmacy Repository | Send Feedback

OpenAIRERCUB
 

 

All of DSpaceCommunitiesAuthorsTitlesSubjectsThis institutionAuthorsTitlesSubjects

Statistics

View Usage Statistics

DSpace software copyright © 2002-2015  DuraSpace
About FarFaR - Pharmacy Repository | Send Feedback

OpenAIRERCUB